Description
Pharma GMP & Regulatory Inspection Audit Checklist (FDA / EMA / SFDA) (2027 Edition)
Engineered for Pharmaceutical Quality Directors, VP of Regulatory Affairs, Qualified Persons (QP), and Biotech Manufacturing Leaders. Prepares pharmaceutical facilities for FDA 483, EMA, and SFDA inspections.
Strategic Problems Solved & Enterprise Risks Prevented
- Prevents FDA Form 483 & Warning Letters: Pre-audits highest-risk inspection observations across sterile injectables and solid dosage.
- Data Integrity Compliance: Implements ALCOA+ principles for electronic laboratory records and chromatography systems.
- Accelerates Batch Release: Eliminates recurring CAPA investigations that stall finished goods delivery.
Exact Turnkey Artifacts Included in Download (.ZIP)
High-Resolution Excel Worksheet Structure
Technical Integrity & Global Regulatory Compliance
Software Compatibility
- Microsoft Excel 365, 2021, 2019, 2016 (PC & Mac)
- Google Sheets Native Import Verified
- Zero circular references; 100% unlocked formula integrity
- Firewall-safe: 0 VBA/macros to prevent corporate proxy quarantine
Regulatory Directives Aligned
- FDA 21 CFR Part 210 & 211 (Current Good Manufacturing Practice)
- EudraLex Volume 4 (EU Guidelines for GMP for Medicinal Products)
- ICH Q9 (Quality Risk Management) and ICH Q10 (Pharmaceutical Quality System)
- Saudi Food & Drug Authority (SFDA) Good Manufacturing Guidelines
90-Day Implementation & Board Cadence
Multi-Seat Corporate Licensing Structure





Reviews
There are no reviews yet.